Lupus Nephritis IgG Induction of Calcium/Calmodulin‐Dependent Protein Kinase IV Expression in Podocytes and Alteration of Their Function
暂无分享,去创建一个
Takahisa Suzuki | Hideki Nakamura | Atsushi Kawakami | Naoki Iwamoto | T. Nishino | G. Tsokos | K. Arima | K. Ichinose | A. Nishino | T. Koga | S. Kawashiri | N. Iwamoto | M. Tamai | Hideki Nakamura | T. Origuchi | A. Kawakami | Y. Obata | Tomoya Nishino | Yoko Obata | George C Tsokos | Kazuhiko Arima | Kunihiro Ichinose | Takeshi Ushigusa | Ayako Nishino | Yosikazu Nakashima | Yoshiro Horai | Tomohiro Koga | Shin-ya Kawashiri | Mami Tamai | Kazuo Yamamoto | Tomoki Origuchi | Kazuo Yamamoto | Y. Horai | Takahisa Suzuki | T. Ushigusa | Y. Nakashima
[1] G. Remuzzi,et al. In response to protein load podocytes reorganize cytoskeleton and modulate endothelin-1 gene: implication for permselective dysfunction of chronic nephropathies. , 2005, The American journal of pathology.
[2] M. Zeier,et al. Role of podocytes in lupus nephritis. , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[3] J. Reiser,et al. Proteinuria: Abate or applaud abatacept in proteinuric kidney disease? , 2014, Nature Reviews Nephrology.
[4] Lee Hebert,et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. , 2004, Kidney international.
[5] T. Rauen,et al. CaMK4-dependent activation of AKT/mTOR and CREM-α underlies autoimmunity-associated Th17 imbalance. , 2014, The Journal of clinical investigation.
[6] E. Lewis,et al. Glomerular podocytopathy in patients with systemic lupus erythematosus. , 2004, Journal of the American Society of Nephrology : JASN.
[7] G. Tsokos,et al. KN-93, an inhibitor of calcium/calmodulin-dependent protein kinase IV, promotes generation and function of Foxp3+ regulatory T cells in MRL/lpr mice , 2014, Autoimmunity.
[8] T. Chan,et al. Mesangial cell-binding anti-DNA antibodies in patients with systemic lupus erythematosus. , 2002, Journal of the American Society of Nephrology : JASN.
[9] K. Kyriacou,et al. Podocyte main slit diaphragm proteins, nephrin and podocin, are affected at early stages of lupus nephritis and correlate with disease histology , 2011, Lupus.
[10] J. Reiser,et al. Abatacept in B7-1-positive proteinuric kidney disease. , 2014, The New England journal of medicine.
[11] Emil R. Unanue,et al. Podocytes use FcRn to clear IgG from the glomerular basement membrane , 2008, Proceedings of the National Academy of Sciences.
[12] J. Kopp,et al. Update in podocyte biology: putting one's best foot forward , 2003, Current opinion in nephrology and hypertension.
[13] Q. Ma,et al. Inhibition of calcium(2+)/calmodulin-dependent protein kinase type IV ameliorates experimental nephrotic syndrome. , 2013, Internal medicine.
[14] R. Zeller,et al. Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines. , 1997, Experimental cell research.
[15] M. Ashburner,et al. Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.
[16] K. Eguchi,et al. Antiangiogenic endostatin peptide ameliorates renal alterations in the early stage of a type 1 diabetic nephropathy model. , 2005, Diabetes.
[17] H. Sugiyama,et al. 2-(8-Hydroxy-6-Methoxy-1-Oxo-1H-2-Benzopyran-3-yl) Propionic Acid, an Inhibitor of Angiogenesis, Ameliorates Renal Alterations in Obese Type 2 Diabetic Mice , 2006, Diabetes.
[18] Yong Cui,et al. Genetic susceptibility to SLE: recent progress from GWAS. , 2013, Journal of autoimmunity.
[19] P. Mundel,et al. Cell biology and pathology of podocytes. , 2012, Annual review of physiology.
[20] M. O'hare,et al. A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression. , 2002, Journal of the American Society of Nephrology : JASN.
[21] K. Lai,et al. The pathogenetic role of immunoglobulin G from patients with systemic lupus erythematosus in the development of lupus pleuritis. , 2003, Rheumatology.
[22] J. Haymann,et al. Characterization and localization of the neonatal Fc receptor in adult human kidney. , 2000, Journal of the American Society of Nephrology : JASN.
[23] R. Kalluri,et al. Induction of B7-1 in podocytes is associated with nephrotic syndrome. , 2004, The Journal of clinical investigation.
[24] T. Rauen,et al. Cutting Edge: Calcium/Calmodulin-Dependent Protein Kinase Type IV Is Essential for Mesangial Cell Proliferation and Lupus Nephritis , 2011, The Journal of Immunology.
[25] J F Fries,et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.
[26] G. Tsokos,et al. Suppression of autoimmunity and organ pathology in lupus-prone mice upon inhibition of calcium/calmodulin-dependent protein kinase type IV. , 2011, Arthritis and rheumatism.
[27] L. Pasquier,et al. Orphanet Journal of Rare Diseases , 2006 .
[28] C. Mawrin,et al. Systemic lupus erythematosus serum IgG increases CREM binding to the IL-2 promoter and suppresses IL-2 production through CaMKIV. , 2005, The Journal of clinical investigation.
[29] M. Saleem,et al. Direct effects of dexamethasone on human podocytes. , 2006, Kidney international.
[30] Dennis B. Troup,et al. NCBI GEO: archive for functional genomics data sets—10 years on , 2010, Nucleic Acids Res..
[31] G. Tsokos,et al. Calcium/Calmodulin-Dependent Protein Kinase IV Suppresses IL-2 Production and Regulatory T Cell Activity in Lupus , 2012, The Journal of Immunology.
[32] F. Gejyo,et al. Differentiation-Induced Cultured Podocytes Express Endocytically Active Megalin, a Heymann Nephritis Antigen , 2004, Nephron Experimental Nephrology.
[33] Anna Maria Masci,et al. Calmodulin-dependent kinase IV links Toll-like receptor 4 signaling with survival pathway of activated dendritic cells. , 2008, Blood.